Subcutaneous Peptide Injection Protocol
The standard administration route for the majority of research and clinical peptides. Subcutaneous injection delivers the peptide into the fat layer under the skin, where it is absorbed gradually into the bloodstream.
How It Works
After reconstitution with bacteriostatic water, the desired dose is drawn into an insulin syringe (typically 29–31 gauge, 0.5 mL capacity). Injection sites include the abdomen (2+ inches from the umbilicus), thighs, or the fatty tissue near the injury site for regenerative peptides. Rotate sites to avoid local tissue hypertrophy or atrophy.
Benefits
Recommended Products (3)
BPC-157
Research-Grade
A 15-amino-acid peptide fragment derived from gastric juice protein BPC, studied extensively in animal models for tissue healing and gut integrity.
CJC-1295 + Ipamorelin
Research-Grade
The most widely used GHRH + GHRP stack — CJC-1295 extends GHRH half-life while Ipamorelin selectively amplifies GH pulses without disturbing cortisol or prolactin.
Tesamorelin
Egrifta
FDA-approved synthetic GHRH analog indicated for HIV-associated lipodystrophy, studied for visceral adipose tissue reduction and cognitive endpoints.